Clinical and biological significance of an isozyme tumor marker--PLAP
- PMID: 3325192
- DOI: 10.1016/0009-9120(87)90003-8
Clinical and biological significance of an isozyme tumor marker--PLAP
Abstract
In 1930 the determination of serum alkaline phosphatase in patients with bone or liver disease ushered in the era of clinical enzymology. The association of elevated (bone) alkaline phosphatase in serum of patients with osteogenic sarcoma was the first evidence that tumor cells themselves produced the enzyme. It became clear, however, in the 1960s that the serum alkaline phosphatase was not a single enzyme but consisted of a family of isozymes originating from liver, bone, intestine, and placenta. This was a consequence of the introduction of a combination of electrophoretic separations, heat inactivation, and organ-specific amino acid inhibitors. This combination of measurements made possible the demonstration of a serum alkaline phosphatase of lung cancer origin, as confirmed by the histochemical visualization in lung cancer of the Regan Isozyme (placental alkaline phosphatase-PLAP). At present, the measurement of PLAP has its greatest utility as a tumor marker in seminoma and ovarian cancer. A PLAP-like isozyme in normal testis and ovary is expressed in these and other neoplasias and appears to be related to rare alleles of placental alkaline phosphatase. Current studies have utilized a panel of monoclonal antibodies to detect useful epitopes that suggest that PLAP and PLAP-like isozymes are coded by different genes. The PLAP gene has now been cloned and sequenced by Millan and others. This fundamental new information is providing a base line that will make it possible to explain the overlapping specificities of intestinal and placental isozymes, the degree of uniqueness of the PLAP-like isozyme, the precise mechanism of uncompetitive inhibition by L-phenylalanine and the evolutionary history of the alkaline phosphatases.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Placental alkaline phosphatase (PLAP)/PLAP-like alkaline phosphatase as tumour marker in relation to CA 125 and TPA for ovarian epithelial tumours.Eur J Gynaecol Oncol. 1990;11(5):351-60. Eur J Gynaecol Oncol. 1990. PMID: 2097151
-
Targeting the active site of the placental isozyme of alkaline phosphatase by phage-displayed scFv antibodies selected by a specific uncompetitive inhibitor.BMC Biotechnol. 2005 Dec 22;5:33. doi: 10.1186/1472-6750-5-33. BMC Biotechnol. 2005. PMID: 16372914 Free PMC article.
-
Levels of alkaline phosphatase isozymes in human seminoma tissue.Cancer Res. 1987 May 15;47(10):2543-6. Cancer Res. 1987. PMID: 3646091
-
Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.Folia Histochem Cytobiol. 2015;53(3):177-88. doi: 10.5603/FHC.a2015.0020. Epub 2015 Aug 26. Folia Histochem Cytobiol. 2015. PMID: 26306513 Review.
-
The 1993 ISOBM Abbott Award Lecture. Isozymes, tumor markers and oncodevelopmental biology.Tumour Biol. 1995;16(6):394-402. Tumour Biol. 1995. PMID: 7569686 Review.
Cited by
-
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer.PLoS One. 2015 Feb 24;10(2):e0117818. doi: 10.1371/journal.pone.0117818. eCollection 2015. PLoS One. 2015. PMID: 25710561 Free PMC article.
-
RNA Sequencing Revealed Signals of Evolution From Gallbladder Stone to Gallbladder Carcinoma.Front Oncol. 2020 May 29;10:823. doi: 10.3389/fonc.2020.00823. eCollection 2020. Front Oncol. 2020. PMID: 32547950 Free PMC article.
-
Enzyme-instructed and mitochondria-targeting peptide self-assembly to efficiently induce immunogenic cell death.Acta Pharm Sin B. 2022 Jun;12(6):2740-2750. doi: 10.1016/j.apsb.2021.07.005. Epub 2021 Jul 14. Acta Pharm Sin B. 2022. PMID: 35755291 Free PMC article.
-
Evaluation of Placental Alkaline Phosphatase Expression as A Potential Target of Solid Tumors Immunotherapy by Using Gene and Protein Expression Repositories.Cell J. 2021 Nov;23(6):717-721. doi: 10.22074/cellj.2021.7299. Epub 2021 Nov 23. Cell J. 2021. PMID: 34939766 Free PMC article.
-
Therapeutic Approaches to Increase the Survival Rate of Cancer Patients in the Younger and Older Population.Curr Aging Sci. 2024;17(1):16-30. doi: 10.2174/0118746098241507231127114248. Curr Aging Sci. 2024. PMID: 38062658 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources